Smith & Nephew plc (LON:SN, NYSE:SNN), the global medical technology business, has announced that John Rogers will succeed Anne-Françoise Nesmes as Chief Financial Officer. He will join the company as..
Smith & Nephew plc (LON:SN, NYSE: SNN), the global medical technology company, has announced the following Board appointments. The Company is pleased to announce that Jeremy (Jez) Maiden and Simon Lowth..
Smith & Nephew (LON:SN, NYSE: SNN), the global medical technology company, has announced that Anne-Françoise Nesmes has informed the Board of her intention to step down as Chief Financial Officer..
Smith & Nephew plc (LON:SN, NYSE: SNN), the global medical technology company, has announced that Anne-Françoise Nesmes has informed the Board of her intention to step down as Chief Financial..
Smith & Nephew plc (LON:SN, NYSE: SNN), the global medical technology business, will announce its trading report for the first quarter ended Saturday, 1 April 2023 on Wednesday, 26 April..
Stock in DS Smith ticker code: LON:SMDS has moved down -1.52% or -5.9 points in today’s trading session so far. Sellers have so far given a mostly negative outlook during..
Shares of PetroNeft Resources with EPIC code: LON:PTR has moved up 4.87% or 0.18 points throughout the session so far. Traders have so far held a positive outlook during the..
Smith & Nephew plc (LON:SN) has announced that, further to the announcement on 18 February 2021, a final dividend of 23.1 US cents per ordinary share in respect of the..
Smith & Nephew plc (LON:SN), the global medical technology business, reports results for the fourth quarter and full year ended 31 December 2020: 31 Dec2020$m 31 Dec2019$m Reportedgrowth% Underlyinggrowth%..
Smith & Nephew plc (LON:SN), the global medical technology business, has announced that it expects a second quarter underlying1 revenue decline of around -29%. This is in line with our..
Smith & Nephew plc (LON:SN) has today issued its trading report for the first quarter ended 28 March 2020. Q1 trading1,2 · Q1 revenue $1,134 million (2019: $1,202 million), down -7.6%..
Smith & Nephew plc (LON:SN), the global medical technology business, has today announced the appointment of Bob White as a Non-Executive Director. Bob is a proven MedTech leader with more..
Smith & Nephew plc (LON:SN), the global medical technology business, has today announced the following changes to the format of its Annual General Meeting to be held at 2:00pm on..
Smith & Nephew Plc (LON:SN), the global medical technology business, has today announced the appointment of Rick Medlock as a Non-Executive Director. Rick will join the Board and Audit Committee..
Smith & Nephew (LON:SN), the global medical technology business, today announced that it has acquired California-based Tusker Medical, Inc., the developer of the Tula System, an in-office solution for tympanostomy..
Smith & Nephew (LON:SN, NYSE:SNN), the global medical technology business, announced its trading report for the third quarter ended 28 September 2019. Highlights Strong Q3 revenue growth, building on the..
Smith & Nephew (LON:SN, NYSE:SNN) announced that Namal Nawana will step down from the Board and his position as Chief Executive Officer (CEO) by mutual agreement on 31 October 2019..
Smith & Nephew (LON: SN), the global medical technology business, has reported its results for the second quarter and first half ended 29 June 2019. Reported ..
Smith & Nephew plc (LON:SN), the global medical technology business, today announced that it has agreed to acquire Atracsys Sàrl, the Switzerland-based provider of optical tracking technology used in computer-assisted..
Smith & Nephew plc (LON:SN, NYSE:SNN), the global medical technology business, today announced it has completed the acquisition of the Brainlab orthopaedic joint reconstruction business. The acquisition supports Smith &..
